FOI release
CEC 208291 Indefinite Ban on Puberty Blockers
This request was refused in part, so we didn't provide some of the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.
Case reference FOI2024/00799
Received 12 December 2024
Published 17 January 2025
Request
I contacting today regarding the advice given to Wes streeting the Health Secretary regarding the indefinite ban on puberty blockers for people under the age of 18. It is my understanding that a consultation has taken place and advice has been given. Would it be possible to find out the exact nature of this advice as the terminology used on the government press release is sensationalised and non specific to the field of medicine and care. It was my understanding that the current position was to approach the use of puberty blockers from a position of neutrality. After contacting the British Medical Association I have been informed that the evaluation into the Cass Review is underway and is yet to be complete. The Cass Review has already been reviewed internationally and has been found to have several major flaws and if this is the basis of the indefinite ban this is rather concerning The effect of GNRH agonists are reversible and this has been the case for many years according to NICE guidelines. The science cannot just change overnight without significant evidence. If that is the case can I please see the evidence. If actions are taking place without the complete evaluation of evidence then this is unconstitutional and against human rights. If this is the case then this is a public issue and must be reported as such. Can I have the relevant information I am requesting and receipt of my request.
Response
see attached
Documents
This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.
You can browse our other responses or make a new FOI request.